Hyderabad to be Global Life Sciences Hub with Biopharma SHAKTI Boost

• Telangana aims to make Hyderabad a leading life sciences hub, contributing to 35% of India's pharmaceutical production.
• The state's 'Next-Gen Life Sciences Policy 2026-2030' aligns with the Centre’s Biopharma SHAKTI initiative, focusing on biologics and biosimilars.
• Chief Minister A Revanth Reddy inaugurated BioAsia 2026, inviting top biopharma companies to establish Global Capability Centres (GCCs) in Hyderabad.
• Major investments include Opella Healthcare expanding its GCC and Vaksindo Animal Health setting up a BSL-3 vaccine manufacturing facility.
• Telangana government will earmark land in Genome Valley for biocatalysis, precision fermentation, and next-gen biomanufacturing.